Back
Essent Group Vs. Gilead Sciences Industry Stock Comparison
Buy
62
ESNT
Essent Group
Last Price:
55.62
Seasonality Move:
6.26%
Sell
42
GILD
Gilead Sciences
Last Price:
68.81
Seasonality Move:
9.98%
Buy
62
Essent Group (ESNT)
is a Buy
Is Essent Group a Buy, Sell or Hold?
- The current Essent Group [ESNT] share price is $55.81. The Score for ESNT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- ESNT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Gilead Sciences (GILD)
is a Sell
Is Gilead Sciences a Buy, Sell or Hold?
- The current Gilead Sciences [GILD] share price is $69.30. The Score for GILD is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- GILD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ESNT Stock Price Chart
What is Essent Group's stock price today?
-
The Essent Group share price today is $55.81
The current trend is moderately bearish and ESNT is experiencing selling pressure, which indicates risk of future bearish movement.
GILD Stock Price Chart
What is Gilead Sciences's stock price today?
-
The Gilead Sciences share price today is $69.30
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GILD is experiencing slight selling pressure.
ESNT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 47.92 | Sell |
| Chaikin Money Flow: | -326882 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.55 - 56.97) | Sell |
| Bollinger Bands (100): | (53.3 - 57.04) | Buy |
GILD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.88 | Buy |
| Relative Strength Index (14 RSI): | 60.73 | Buy |
| Chaikin Money Flow: | -1753439 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.34 - 68.02) | Buy |
| Bollinger Bands (100): | (65.45 - 73.33) | Sell |
ESNT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.17 | Sell |
| 20-day SMA: | 56.33 | Sell |
| 50-day SMA: | 55.53 | Buy |
| 200-day SMA: | 52.6 | Buy |
| 8-day EMA: | 56.31 | Sell |
| 20-day EMA: | 56.22 | Sell |
| 50-day EMA: | 55.86 | Sell |
| 200-day EMA: | 52.92 | Buy |
GILD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 67.66 | Buy |
| 20-day SMA: | 65.56 | Buy |
| 50-day SMA: | 66 | Buy |
| 200-day SMA: | 73.99 | Sell |
| 8-day EMA: | 68.16 | Buy |
| 20-day EMA: | 66.7 | Buy |
| 50-day EMA: | 67.06 | Buy |
| 200-day EMA: | 72.21 | Sell |
Essent Group Earnings Growth & ESNT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.11 per share, an increase this year of $0.24 per share, and an increase next year of $0.36 per share.
Gilead Sciences Earnings Growth & GILD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.01 per share, a decrease this year of $3.05 per share, and an increase next year of $3.46 per share.
Essent Group Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Gilead Sciences Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||